Proactive Highlights Custom Health’s Growth and Expansion Strategy
Custom Health was recently featured in Proactive following the release of its second-quarter 2026 financial results, which reported revenue of US$7.4 million—a 70% increase compared with the same period last year.
The article highlights Custom Health’s continued growth following the acquisition of InnovativeRx and the company’s progress toward building a more connected medication management platform. It also discusses the proposed acquisition of Evergreen Pharmacy and the agreement to acquire Spencer Health Solutions, bringing the spencer smart in-home medication dispensing and monitoring platform fully under Custom Health’s control.
Together, these developments are expected to strengthen the alignment between technology, pharmacy services and clinical care, supporting Custom Health’s ability to help patients manage their medications safely and effectively at home.
If both transactions are completed, Custom Health expects to surpass a US$130 million annualized revenue run rate by the end of 2026.
Read the full article on Proactive
